The
following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they
would be anti-dilutive:
Schedule
of Potentially Dilutive Securities Excluded from Computation of Diluted Shares
|
|
2024 |
|
|
2023 |
|
|
|
September
30, |
|
|
|
2024 |
|
|
2023 |
|
Common stock warrants August 2021 |
|
|
14,031 |
|
|
|
16,039 |
|
Underwriter warrants August 2021 |
|
|
284 |
|
|
|
284 |
|
Chanticleer warrants |
|
|
6 |
|
|
|
6 |
|
Series C warrants |
|
|
2,297 |
|
|
|
4,591 |
|
Series 3 warrants |
|
|
1,566 |
|
|
|
1,566 |
|
Unvested restricted stock units and awards |
|
|
17,152 |
|
|
|
288 |
|
Common stock warrants February 2023 |
|
|
33,982 |
|
|
|
33,982 |
|
Underwriter warrants February 2023 |
|
|
1,933 |
|
|
|
5,523 |
|
Common stock private placement warrants June
2023 |
|
|
28,409 |
|
|
|
28,409 |
|
Placement agent warrants June 2023 |
|
|
852 |
|
|
|
852 |
|
Common stock warrants October 2023 |
|
|
354,994 |
|
|
|
— |
|
Underwriter warrants October 2023 |
|
|
10,664 |
|
|
|
— |
|
Placement agent warrants June 2024 |
|
|
14,142 |
|
|
|
— |
|
Common stock warrants
June 2024 |
|
|
703,125 |
|
|
|
— |
|
Total
anti-dilutive weighted average shares |
|
|
1,183,437 |
|
|
|
91,540 |
|
|